The path to commercializing cell and gene therapies can vary around the world. In the latest episode of Commercializing Living Therapies with CCRM, I speak with Sarah Callens & Silvio Tiziani about the strengths and obstacles of their regional cell and gene therapy ecosystems. https://www.ccrm.ca/podcast/